CMPX
Compass Therapeutics, Inc.
- Latest sale
- $5.7M
- Apr 9 · Unusual
- Form 4 sales
- 4
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Timeline
- 1 Form 4 salePlan not statedNov 21 2022
Sold 22,261 shares at $4.36 ($97k)
Bisker-Leib Vered, Chief Operating Officer
Sold 2% of holdings ($4.8M position)1.1M shares leftFirst sale on recordFiling
- 2 Form 4 salePlan not statedNov 25 +4 days
Sold 24,500 shares at $4.23 ($104k)
Bisker-Leib Vered, Chief Operating Officer
Sold 2.3% of holdings ($4.6M position)1.1M shares leftFiling
- 3 Form 4 saleUnusualApr 9 +866 days
Sold 3.6M shares at $1.59 ($5.7M)
OrbiMed Capital GP VI LLC, Director, 10% owner
No 10b5-1 planSold 100% of holdings ($5.7M position)0 shares leftFirst sale on recordFiling
- 4 Form 4 saleUnusualApr 9 same day
Sold 3.6M shares at $1.59 ($5.7M)
Gordon Carl L, Director, 10% owner
No 10b5-1 planSold 100% of holdings ($5.7M position)0 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (4)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2025 | Gordon Carl L | Director, 10% owner | Form 4 sale | 3.6M | $5.7M | 100.0% | Unusual | SEC |
| Apr 9, 2025 | OrbiMed Capital GP VI LLC | Director, 10% owner | Form 4 sale | 3.6M | $5.7M | 100.0% | Unusual | SEC |
| Nov 25, 2022 | Bisker-Leib Vered | Chief Operating Officer | Form 4 sale | 24,500 | $104k | 2.3% | Plan not stated | SEC |
| Nov 21, 2022 | Bisker-Leib Vered | Chief Operating Officer | Form 4 sale | 22,261 | $97k | 2.0% | Plan not stated | SEC |